Which nerve block combo best eases pain after gynecologic cancer surgery?

NCT ID NCT07312825

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 94 patients who had major abdominal surgery for gynecologic cancers. Researchers compared pain relief from a standard nerve block (TAP block) alone versus combining it with another block (QLB or RSB). The goal was to see which approach reduced pain and opioid use after surgery. All blocks were given as part of routine care, not assigned by the study.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

nerve blocks (TAP block, Quadratus Lumborum block, Rectus Sheath block)

What this could lead to

If it works, this could point toward a better way to manage pain after gynecologic cancer surgery, possibly reducing opioid use and speeding recovery.

What could go wrong

This is an observational study, not a randomized trial, so results may be influenced by patient differences. It is also small (94 patients) and completed, so findings need confirmation in larger trials.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

endometrial cancer female reproductive organ cancer ovarian neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital

    Ankara, Turkey (Türkiye)